Skip to main content

Table 3 Topic raised according to type of sarcoma

From: Use of a simple form to facilitate communication on long-term consequences of treatment in sarcoma survivors

Topic

Diagnosis

N (%)

Crude OR (95% CI)

P-value

Adjusted ORa (95% CI)

P-value

Pain

STS

27/106 (26)

1.0 (ref)

 

1.0 (ref)

 

BS

19/54 (35)

1.6 (0.8–3.2)

0.20

1.5 (0.7–3.3)

0.36

Fatigue

STS

32/106 (30)

1.0

 

1.0

 

BS

31/54 (57)

3.1 (1.6–6.2)

0.001

3.1 (1.4–6.7)

0.004

Bowel/urination

STS

5/106 (5)

1.0

 

1.0

 

BS

2/54 (4)

0.8 (0.1–4.1)

0.77

0.6 (.01–4.1)

0.59

Sexual

STS

9/106 (8)

1.0

 

1.0

 

BS

11/54 (20)

2.8 (1.1–7.1)

0.04

2.6 (0.8–7.7)

0.10

Mobility

STS

20/106 (19)

1.0

 

1.0

 

BS

16/54 (30)

1.8 (0.8–3.9)

0.11

1.9 (0.8–4.5)

 

Psychological

STS

8/106 (8)

1.0

 

1.0

 

BS

11/54 (20)

3.1 (1.2–8.3)

0.02

2.9 (0.9–8.5)

0.05

Other

STS

14/106 (13)

1.0

 

1.0

 

BS

9/54 (17)

1.3 (0.5–3.3)

0.56

1.4 (0.5–4.1)

0.50

Peer

STS

3/106 (3)

1.0

 

1.0

 

BS

7/54 (13)

5.1 (1.3–21)

0.02

10 (2.0–54)

0.005

No topic

STS

16/106 (15)

1.0

 

1.0

 

BS

4/54 (7)

0.4 (0.1–1.4)

0.17

0.5 (0.1–1.8)

0.27

  1. N are presented as number of patients that raised the topic within the diagnosis group with % in the brackets
  2. Italic values indicate significance of P-value (P < 0.05)
  3. STS soft-tissue sarcoma, BS bone sarcoma, OR odds ratio, CI confidence interval, ref reference
  4. aAdjusted for age and gender